concept

APRIL

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about APRIL: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

16Connections

0Hypotheses

0Analyses

14Outgoing

2Incoming

0Experiments

0Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	APRIL
Key Genes/Proteins	HEPARAN SULFATE PROTEOGLYCANS, HSPG2
Related Diseases	atherosclerosis, Atherosclerosis, cardiovascular disease

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

AAN 2026 — Deep Brain Stimulation and Neurotechnology Advances

event · 2310 words

→

Pathway Diagram

graph TD
    APRIL[APRIL]
    APRIL -->|binds| Heparan_Sulfate_Proteoglycans[Heparan Sulfate Proteoglycans]
    APRIL -->|binds| HEPARAN_SULFATE_PROTEOGLYCANS[HEPARAN SULFATE PROTEOGLYCANS]
    APRIL -->|inhibits| Atherosclerosis[Atherosclerosis]
    APRIL -->|inhibits| Atherosclerosis_Progression[Atherosclerosis Progression]
    APRIL -->|binds_to| HSPG2[HSPG2]
    APRIL -->|limits| atherosclerosis[atherosclerosis]

Outgoing (14)

Target	Relation	Type	Str
HEPARAN SULFATE PROTEOGLYCANS	binds	protein	0.95
Atherosclerosis	inhibits	disease	0.95
Heparan Sulfate Proteoglycans	binds	compound	0.95
Heparan Sulfate Proteoglycans	interacts_with	receptor	0.92
atherosclerosis	limits	disease	0.90
Atherosclerosis Progression	inhibits	process	0.90
Atherosclerosis	protects_against	disease	0.90
Heparan Sulfate Proteoglycans	binds_to	protein	0.90
HSPG2	binds_to	protein	0.90
Low-Density Lipoproteins	limits_retention	molecule	0.80
atherosclerosis	inhibits	disease	0.80
macrophages	limits_accumulation	cell	0.80
Necrotic Cores	limits_formation	pathological_structure	0.80
cardiovascular disease	therapeutic_target	disease	0.75

Incoming (2)

Source	Relation	Type	Str
34433968	limits	paper	0.90
34433968	confers atheroprotection by binding to	paper	0.90

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning APRIL in their description or question text

No additional research found